114 related articles for article (PubMed ID: 22509853)
1. Toward the reliable diagnosis of indeterminate thyroid lesions: a HRMAS NMR-based metabolomics case of study.
Torregrossa L; Shintu L; Nambiath Chandran J; Tintaru A; Ugolini C; Magalhães A; Basolo F; Miccoli P; Caldarelli S
J Proteome Res; 2012 Jun; 11(6):3317-25. PubMed ID: 22509853
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of post-surgical fine-needle aspiration biopsies of thyroid lesions with indeterminate cytology using HRMAS NMR-based metabolomics.
Rezig L; Servadio A; Torregrossa L; Miccoli P; Basolo F; Shintu L; Caldarelli S
Metabolomics; 2018 Oct; 14(10):141. PubMed ID: 30830426
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics approach to thyroid nodules: a high-resolution magic-angle spinning nuclear magnetic resonance-based study.
Miccoli P; Torregrossa L; Shintu L; Magalhaes A; Chandran J; Tintaru A; Ugolini C; Minuto MN; Miccoli M; Basolo F; Caldarelli S
Surgery; 2012 Dec; 152(6):1118-24. PubMed ID: 23158182
[TBL] [Abstract][Full Text] [Related]
4. Follicular lesions of the thyroid.
Mathur A; Olson MT; Zeiger MA
Surg Clin North Am; 2014 Jun; 94(3):499-513. PubMed ID: 24857573
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the role of magnetic resonance spectroscopy in the diagnosis of follicular malignancies of thyroid.
Gupta N; Goswami B; Chowdhury V; Ravishankar L; Kakar A
Arch Surg; 2011 Feb; 146(2):179-82. PubMed ID: 21339429
[TBL] [Abstract][Full Text] [Related]
6. Proton magnetic resonance and human thyroid neoplasia. II: Potential avoidance of surgery for benign follicular neoplasms.
Delbridge L; Lean CL; Russell P; May GL; Roman S; Dowd S; Reeve TS; Mountford CE
World J Surg; 1994; 18(4):512-6; discussion 516-7. PubMed ID: 7725737
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsy.
Williams MD; Suliburk JW; Staerkel GA; Busaidy NL; Clayman GL; Evans DB; Perrier ND
Ann Surg Oncol; 2009 Nov; 16(11):3146-53. PubMed ID: 19727961
[TBL] [Abstract][Full Text] [Related]
8. Risk of malignancy in follicular thyroid neoplasm: predictive value of thyrotropin.
Zimny M; Selkinski I; Blasius S; Rink T; Schroth HJ; Grünwald F
Nuklearmedizin; 2012; 51(4):119-24. PubMed ID: 22526481
[TBL] [Abstract][Full Text] [Related]
9. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
[TBL] [Abstract][Full Text] [Related]
10. Molecular phenotyping of thyroid tumors identifies a marker panel for differentiated thyroid cancer diagnosis.
Wiseman SM; Melck A; Masoudi H; Ghaidi F; Goldstein L; Gown A; Jones SJ; Griffith OL
Ann Surg Oncol; 2008 Oct; 15(10):2811-26. PubMed ID: 18612701
[TBL] [Abstract][Full Text] [Related]
11. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
12. Fine needle aspiration biopsy of follicular thyroid tumors.
Pauzar B; Staklenac B; Loncar B
Coll Antropol; 2010 Mar; 34(1):87-91. PubMed ID: 20432738
[TBL] [Abstract][Full Text] [Related]
13. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
[TBL] [Abstract][Full Text] [Related]
14. Genetic markers differentiating follicular thyroid carcinoma from benign lesions.
Freitas BC; Cerutti JM
Mol Cell Endocrinol; 2010 May; 321(1):77-85. PubMed ID: 19932149
[TBL] [Abstract][Full Text] [Related]
15. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
Aron M; Kapila K; Verma K
Indian J Pathol Microbiol; 2006 Jul; 49(3):376-80. PubMed ID: 17001889
[TBL] [Abstract][Full Text] [Related]
16. [Follicular and Hurthle cell tumors of the thyroid gland. Possibilities of preoperative differential diagnosis].
Grineva EN; Goriushkina EV; Malakhova TV; Tsoĭ UA
Vopr Onkol; 2004; 50(1):41-5. PubMed ID: 15088519
[TBL] [Abstract][Full Text] [Related]
17. Thyroid follicular lesion of undetermined significance: Evaluation of the risk of malignancy using the two-tier sub-classification.
Horne MJ; Chhieng DC; Theoharis C; Schofield K; Kowalski D; Prasad ML; Hammers L; Udelsman R; Adeniran AJ
Diagn Cytopathol; 2012 May; 40(5):410-5. PubMed ID: 22508675
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance spectroscopy as a diagnostic modality for carcinoma thyroid.
Gupta N; Kakar AK; Chowdhury V; Gulati P; Shankar LR; Vindal A
Eur J Radiol; 2007 Dec; 64(3):414-8. PubMed ID: 17462842
[TBL] [Abstract][Full Text] [Related]
19. Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns.
Eszlinger M; Paschke R
Mol Cell Endocrinol; 2010 Jun; 322(1-2):29-37. PubMed ID: 20083161
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of human follicular thyroid adenomas from carcinomas by gene expression profiling.
Zhao J; Leonard C; Gemsenjäger E; Heitz PU; Moch H; Odermatt B
Oncol Rep; 2008 Feb; 19(2):329-37. PubMed ID: 18202778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
